Concepedia
Statistics
Publications
11
Citations
493
H-Index
Active since
2006
Affiliations
Novartis (Switzerland)(Current)
Friedrich Schiller University Jena
Novartis Institutes for BioMedical Research
University Hospital of Basel
Utrecht University
Kamal K. Balavenkatraman is an author at Novartis (Switzerland) specializing in life sciences, medicine, and molecular biology.
Publications per year
2006–2023
DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients
Kamal K. Balavenkatraman, Enrico Jandt, Karlheinz Friedrich et al. · Oncogene · 2006 · 75 citations
Life Sciences, Molecular Biology, Oncology +15
Apple Polyphenols Affect Protein Kinase C Activity and the Onset of Apoptosis in Human Colon Carcinoma Cells
Melanie Kern, Gudrun Pahlke, Kamal K. Balavenkatraman et al. · Journal of Agricultural and Food Chemistry · 2007 · 66 citations
Medicine, Cancer Biology, Oncology +17
Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice
Derya R. Shimshek, Laura H. Jacobson, Carine Kolly et al. · Scientific Reports · 2016 · 66 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser et al. · Nature Biotechnology · 2022 · 60 citations · Full text
Life Sciences, Infectious Diseases, Pharmacology +15
Loss of the Protein‐Tyrosine Phosphatase DEP‐1/PTPRJ Drives Meningioma Cell Motility
Astrid Petermann, Daniela Haase, Andrea Wetzel et al. · Brain Pathology · 2010 · 50 citations · Full text
Life Sciences, Cancer Biology, Molecular Biology +17
1–5 of 11